Outcomes and prognostic factors associated with 180-day mortality in Taiwanese pediatric patients with Hemophagocytic Lymphohistiocytosis
Open Access
- 17 November 2020
- journal article
- research article
- Published by Elsevier BV in Journal of the Formosan Medical Association
- Vol. 120 (4), 1061-1068
- https://doi.org/10.1016/j.jfma.2020.10.026
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST-109023140B0002-156)
This publication has 38 references indexed in Scilit:
- Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocolBlood, 2011
- Risk factors for early death in children with haemophagocytic lymphohistiocytosisActa Paediatrica, 2011
- Hemophagocytosis causes a consumptive anemia of inflammationThe Journal of Experimental Medicine, 2011
- Impaired plasma lipid profiles in acute hepatitisLipids in Health and Disease, 2010
- UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosisHaematologica, 2009
- Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13‐4 polymorphismsArthritis & Rheumatism, 2008
- Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantationBlood, 2002
- DIFFERENTIAL REGULATION OF LIPOPROTEIN LIPASE IN THE MACROPHAGE J774.2 CELL LINE BY CYTOKINESCytokine, 1996
- Lipoprotein Alterations and Plasma Lipoprotein Lipase Reduction in Familial Hemophagocytic LymphohistiocytosisActa Paediatrica, 1991
- PURE RED CELL APLASIA IN ASSOCIATION WITH VIRUS ASSOCIATED HAEMOPHAGOCYTIC SYNDROME (VAHS)British Journal of Haematology, 1989